HER 2 LOW-EXPRESSING BREAST CANCER
Clinical trials for HER 2 LOW-EXPRESSING BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 LOW-EXPRESSING BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 LOW-EXPRESSING BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PET tracer aims to sharpen view of HER2 cancers
Diagnosis Not yet recruitingThis early-phase study will test a radioactive tracer called [68Ga]Ga-ABY-025 during PET scans to see if it can better identify HER2-positive tumors in people with advanced or metastatic cancer. About 30 adults who are already receiving standard HER2-targeted therapy will receive…
Matched conditions: HER 2 LOW-EXPRESSING BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
New study aims to use PET scans to spot Non-Responders early in HER2 low breast cancer
Knowledge-focused Not yet recruitingThis study looks at whether a special type of PET scan can detect if the drug trastuzumab deruxtecan is working earlier than standard CT scans in people with HER2 low breast cancer that has spread. About 262 participants will be followed to compare PET and CT results. The goal is…
Matched conditions: HER 2 LOW-EXPRESSING BREAST CANCER
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC